Neoadjuvant PD-1 Blockade in Resectable Lung Cancer. (Q52586562)

http://europepmc.org/abstract/MED/29658848

4 May 2018

title

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

Jiajia Zhang

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

29

Jedd D Wolchok

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

32

Victor E Velculescu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

9

David R Jones

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

28

Valerie Rusch

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

author name string

Patrick M Forde

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

Jamie E Chaft

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

Kellie N Smith

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

Valsamo Anagnostou

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

Tricia R Cottrell

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

Marianna Zahurak

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

Stephen C Yang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

Stephen Broderick

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

Richard J Battafarano

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

Moises J Velez

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

Natasha Rekhtman

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

Zachary Olah

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

Jarushka Naidoo

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

Kristen A Marrone

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

Franco Verde

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

Haidan Guo

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

Justina X Caushi

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

Hok Yee Chan

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

John-William Sidhom

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

Robert B Scharpf

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

James White

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

Edward Gabrielson

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

Hao Wang

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

Gary L Rosner

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

Taha Merghoub

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

Janis M Taube

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

Suzanne L Topalian

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

Julie R Brahmer

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

Drew M Pardoll

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

language of work or name

English

0 references

publication date

16 April 2018

1 reference

http://europepmc.org/abstract/MED/29658848

4 May 2018

number of pages

11

1 reference

The New England Journal of Medicine

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

volume

378

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

page(s)

1976-1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

issue

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

Toxicity and response criteria of the Eastern Cooperative Oncology Group

12 May 2020

cites work

1 reference

12 December 2020

Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells

1 reference

12 December 2020

The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours

1 reference

12 December 2020

Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group

1 reference

12 December 2020

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

12 December 2020

Do we need a different set of response assessment criteria for tumor immunotherapy?

1 reference

12 December 2020

Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape

1 reference

12 December 2020

Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy

1 reference

12 December 2020

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

1 reference

12 December 2020

Comprehensive genomic characterization of squamous cell lung cancers

1 reference

12 December 2020

Palindromic nucleotide analysis in human T cell receptor rearrangements

1 reference

12 December 2020

Phase II trial of neoadjuvant bevacizumab plus chemotherapy and adjuvant bevacizumab in patients with resectable nonsquamous non-small-cell lung cancers.

1 reference

12 December 2020

Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint

1 reference

12 December 2020

PD-1 blockade induces responses by inhibiting adaptive immune resistance

1 reference

12 December 2020

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

1 reference

12 December 2020

Personalized genomic analyses for cancer mutation discovery and interpretation

1 reference

12 December 2020

Pembrolizumab for the treatment of non-small-cell lung cancer

1 reference

12 December 2020

Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer

1 reference

12 December 2020

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

1 reference

12 December 2020

Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade

1 reference

12 December 2020

Evaluation of Immune-Related Response Criteria and RECIST v1.1 in Patients With Advanced Melanoma Treated With Pembrolizumab

1 reference

12 December 2020

PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.

1 reference

12 December 2020

Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.

1 reference

12 December 2020

Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease.

1 reference

12 December 2020

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer

1 reference

12 December 2020

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial.

1 reference

12 December 2020

Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer.

1 reference

12 December 2020

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.

1 reference

12 December 2020

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.

1 reference

12 December 2020

Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial.

1 reference

12 December 2020

Identifiers

DOI

10.1056/NEJMOA1716078

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6223617&resulttype=core&format=json

12 May 2020

1 reference